Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for hospitalized patients with COVID-19
IRCT20181208041886N3Phase 3Completed
- Sponsor
- Dr. Abidi Pharmaceuticals
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of montelukast in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Dr. Abidi Pharmaceuticals. Primary endpoints: Clinical condition, Blood oxygen saturation and 2 more. Started Dec 2020; status: completed.
02
Drugs
montelukast
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20181208041886N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181208041886N3.